Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2019 14:15 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019

BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
April 22, 2019 08:45 ET | Source: Teligent, Inc.

Teligent Provides Update on Orphan Drug Complete Response Letter

BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development...
April 12, 2019 15:00 ET | Source: Teligent, Inc.

Teligent, Inc. Management Comments on Recent Market Movements

BUENA, N.J., April 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today provided commentary on the recent market movements...
April 04, 2019 08:54 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1%

BUENA, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
March 19, 2019 14:06 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05%

BUENA, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
March 18, 2019 07:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Fourth Quarter and Year End 2018 Results

BUENA, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...
March 15, 2019 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019

BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31st Annual ROTH Conference March...
March 14, 2019 08:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Desonide Ointment, 0.05%

BUENA, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
March 12, 2019 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Fourth Quarter 2018 Results

BUENA, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 8:00am...
February 27, 2019 13:08 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at The 8th Annual SVB Leerink Global Healthcare Conference Friday March 1, 2019

BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8th Annual SVB Leerink Global...